Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients

Despite remarkable progress in melanoma therapy, the exceptional heterogeneity of the disease has prevented the development of reliable companion biomarkers for the prediction or monitoring of therapy responses. Here, we show that difficulties in detecting blood-based markers, like circulating tumor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Gorges, Katharina, Wiltfang, Lisa, Gorges, Tobias M., Sartori, Alexander, Hildebrandt, Lina, Keller, Laura, Volkmer, Beate, Peine, Sven, Babayan, Anna, Moll, Ingrid, Schneider, Stefan W., Twarock, Sören, Mohr, Peter, Fischer, Jens W., Pantel, Klaus
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6896052/
https://ncbi.nlm.nih.gov/pubmed/31671846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11111685
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados